Volume overload is a major characteristic in primary aldosteronism: a 3-year follow-up study

被引:2
|
作者
Kokko, Eeva [1 ]
Choudhary, Manoj Kumar [1 ]
Mutanen, Aapo [1 ]
Honkonen, Milja [1 ]
Tikkakoski, Antti [1 ,2 ]
Koskela, Jenni K. [1 ,3 ]
Haemaelaeinen, Mari [1 ,4 ]
Moilanen, Eeva [1 ,4 ]
Viukari, Marianna [5 ]
Matikainen, Niina [5 ]
Nevalainen, Pasi I. [3 ]
Poersti, Ilkka [1 ,3 ]
机构
[1] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland
[2] Tampere Univ Hosp, Dept Clin Physiol & Nucl Med, Tampere, Finland
[3] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland
[4] Tampere Univ, Tampere Univ Hosp, Immunopharmacol Res Grp, Tampere, Finland
[5] Univ Helsinki, Res Programs Unit, Clin & Mol Med, Helsinki, Finland
关键词
adrenalectomy; extracellular water volume; haemodynamics; primary aldosteronism; spironolactone; TREATED PRIMARY ALDOSTERONISM; BODY-FLUID VOLUMES; RESISTANT HYPERTENSION; ARTERIAL STIFFNESS; WAVE REFLECTION; BLOOD-PRESSURE; IMPEDANCE; SPIRONOLACTONE; MORTALITY; DIAGNOSIS;
D O I
10.1097/HJH.0000000000003696
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objectives:We examined haemodynamics, focusing on volume balance and forward and backward wave amplitudes, before and after 2.8 years of targeted treatment of primary aldosteronism. Patients with essential hypertension and normotensive individuals were examined for comparison (n = 40 in each group). Methods:Recordings were performed using radial artery pulse wave analysis and whole-body impedance cardiography. Unilateral aldosteronism was treated with adrenalectomy (n = 20), bilateral aldosteronism with spironolactone-based medication (n = 20), and essential hypertension with standard antihypertensive agents. Results:Aortic SBP and DBP, forward and backward wave amplitudes, and systemic vascular resistance were equally elevated in primary aldosteronism and essential hypertension. All these haemodynamic variables were similarly reduced by the treatments. Primary aldosteronism presented with 1 litre (similar to 10%) extracellular water excess (P < 0.001) versus the other groups, and this excess was normalized by treatment. Initial pulse wave velocity (PWV) was similarly increased in primary aldosteronism and essential hypertension, but final values remained higher in primary aldosteronism (P < 0.001). In regression analyses, significant explanatory factors for treatment-induced forward wave amplitude reduction were decreased systemic vascular resistance (beta = 0.380) and reduced extracellular water volume (beta = 0.183). Explanatory factors for backward wave amplitude reduction were changes in forward wave amplitude (beta = 0.599), heart rate (beta = -0.427), and PWV (beta = 0.252). Conclusion:Compared with essential hypertension, the principal haemodynamic difference in primary aldosteronism was higher volume load. Volume excess elevated forward wave amplitude, which was subsequently reduced by targeted treatment of primary aldosteronism, along with normalization of volume load. We propose that incorporating extracellular water evaluation alongside routine diagnostics could enhance the identification and diagnosis of primary aldosteronism.
引用
收藏
页码:1057 / 1065
页数:9
相关论文
共 50 条
  • [1] 3-year follow-up of the NIMH MTA study
    Jensen, Peter S.
    Arnold, L. Eugene
    Swanson, James M.
    Vitiello, Benedetto
    Abikoff, Howard B.
    Greenhill, Laurence L.
    Hechtman, Lily
    Hinshaw, Stephen P.
    Pelham, Willim E.
    Wells, Karen C.
    Conners, Keith
    Elliott, Glen F.
    Epstein, Jeffery N.
    Hoza, Betsy
    March, John S.
    Molina, Brooke S. G.
    Newcorn, Jeffre-Y H.
    Severe, Joanne B.
    Wigal, Timothy
    Gibbons, Robert D.
    Hur, Kwan
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2007, 46 (08): : 989 - 1002
  • [2] A 3-year follow-up of the Silent Diabetes Study
    Schnell, Oliver
    Doerr, Rolf
    Lodwig, Volker
    Weissmann, Joerg
    Lohmann, Tobias
    DIABETOLOGIA, 2014, 57 (12) : 2596 - 2598
  • [3] BRIGHT DELINQUENTS - 3-YEAR FOLLOW-UP STUDY
    TENNENT, G
    GATH, D
    BRITISH JOURNAL OF CRIMINOLOGY, 1975, 15 (04): : 386 - 390
  • [4] A 3-year follow-up of the Silent Diabetes Study
    Oliver Schnell
    Rolf Doerr
    Volker Lodwig
    Joerg Weissmann
    Tobias Lohmann
    Diabetologia, 2014, 57 : 2596 - 2598
  • [5] A 3-year follow-up study of 'orientation agnosia'
    Fujinaga, N
    Muramatsu, T
    Ogano, M
    Kato, M
    NEUROPSYCHOLOGIA, 2005, 43 (08) : 1222 - 1226
  • [6] PROPOSED 3-YEAR FOLLOW-UP
    COCHRAN, JH
    PLASTIC AND RECONSTRUCTIVE SURGERY, 1992, 89 (02) : 386 - 386
  • [7] 3-YEAR FOLLOW-UP STUDY OF ABUSED AND NEGLECTED CHILDREN
    FRIEDMAN, SB
    MORSE, CW
    SAHLER, OJZ
    PEDIATRIC RESEARCH, 1970, 4 (05) : 474 - &
  • [8] A 3-YEAR FOLLOW-UP STUDY OF ABUSED AND NEGLECTED CHILDREN
    MORSE, CW
    SAHLER, JZ
    FRIEDMAN, SB
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1970, 120 (05): : 439 - &
  • [9] 3-YEAR FOLLOW-UP OF THE FLUOROURACIL FILTERING SURGERY STUDY
    ALWARD, WLM
    FARRELL, T
    HAYREH, S
    KOLDER, H
    CARNEY, B
    PHELPS, C
    GRESSEL, M
    COSTIN, J
    CRAVEN, P
    ZGRABIK, M
    SCHREMP, P
    SIMASHKEVICH, B
    HEUER, DK
    BAERVELDT, G
    MINCKLER, D
    IRVINE, J
    SADUN, A
    GREEN, R
    MCDONNELL, P
    LLOYD, M
    OBER, RR
    WALONKER, F
    PADILLA, M
    MARTONE, J
    LIGGETT, P
    LEAN, J
    GRIFFAY, E
    MILLERSCHOLTE, A
    KASS, M
    KOLKER, A
    FARBER, M
    GANS, L
    SMITH, M
    JONES, A
    KLENKE, S
    OWENSBY, A
    PARRISH, RK
    HODAPP, E
    PALMBERG, PF
    ANDERSON, DR
    DELCALVO, M
    MULE, M
    CARTER, A
    FAJARDO, A
    ROSARIO, Y
    SHERWOOD, M
    STERN, G
    DRIEBE, W
    GUY, J
    ADI, M
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1993, 115 (01) : 82 - 92
  • [10] Hypokalemic periodic paralysis: a 3-year follow-up study
    Holm-Yildiz, Sonja
    Krag, Thomas
    Witting, Nanna
    Pedersen, Britt Staevnsbo
    Dysgaard, Tina
    Sloth, Louise
    Pedersen, Jonas
    Kjaer, Rebecca
    Kannuberg, Linda
    Dahlqvist, Julia
    Borch, Josefine de Stricker
    Solheim, Tuva
    Fornander, Freja
    Eisum, Anne-Sofie
    Vissing, John
    JOURNAL OF NEUROLOGY, 2023, 270 (12) : 6057 - 6063